One share of BIIB stock can currently be purchased for approximately $270.01. Looking for new stock ideas? A A's AMD AMD's AOL AOL's AWS AWS's Aachen Aachen's Aaliyah Aaliyah's Aaron Aaron's Abbas Abbas's Abbasid Abbasid's Abbott Abbott's Abby Abby's Abdul Abdul's Abe Abe's Abel Abel's Biogen NZ Biopharma Limited. Biogen Careers 13 Jobs in Switzerland Featured Jobs; E2E Product SC Senior Planner. VP and Head, AbbVie Ventures, Boston/Chicago. Copyright © 2008–2021, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. How much do Biogen employees make? © American Consumer News, LLC dba MarketBeat® 2010-2021. Biogen does not currently pay a dividend. (Add your “outperform” vote. In December 2014, we received a request from Biogen to find a suitable location for a production facility in Switzerland. BIIB stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Price T Rowe Associates Inc. MD, Armistice Capital LLC, Primecap Management Co. CA, Assenagon Asset Management S.A., Vontobel Holding Ltd., Morgan Stanley, and Van ECK Associates Corp. Company insiders that have bought Biogen stock in the last two years include Alexander J Denner, and Michel Vounatsos. New biogen careers in Cambridge, MA are added daily on SimplyHired.com. View analysts' price targets for Biogen or view top-rated stocks among Wall Street analysts. The perfect match. Full-time. In the past three months, Biogen insiders have not sold or bought any company stock. Commercial Release Specialist Parenteral. VP of Pharmaceutical Operations & Technology, Start Your Risk-Free Trial Subscription Here, Attack on Saudi oil site fuels upward march for crude prices, Spanish food delivery riders want right to be self-employed, Stocks rise broadly on Wall Street even as technology lags, Airline stocks rally, American cites plan to pay off loan, Meme fav GameStop jumps again as retailer eyes digital shift, Cyprus, Israel, Greece sign deal on electric cable link, Great Time to Buy Goodyear Tires (NYSE: GT) Stock Here, Hereâs Where the S&P 500 (NYSEARCA: SPY) Can Go From Here, Xpeng, Inc (NYSE:XPEV) Is Loaded For Growth, Vuzix Eyeing Partnerships For Its Augmented Reality Glasses, The Childrenâs Place Could Benefit From a Post-Vaccine Baby Boom, V.F. Biogen Careers 8 Jobs in Luterbach, CHE ... Switzerland Sr. Biogen updated its FY 2021 He also obtained multiple certifications from the American Society for Quality. High institutional ownership can be a signal of strong market trust in this company. The new facility could lead to approximately 90 new jobs once fully operational. Michel Vounatsos has an approval rating of 86% among Biogen's employees. Corporation Stock Makes a New Buy Case on Improving Analyst Picture, Big Lots Follows North Star To Profits, You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Donât Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Biogen Inc. stock outperforms market despite losses on the day - MarketWatch, Alkermes, Inc. -- Moody's assigns Ba3 to Alkermes' term loan; stable outlook, Here's What Biogen Inc.'s (NASDAQ:BIIB) Shareholder Ownership Structure Looks Like - Yahoo Finance, Here's What Biogen Inc.'s (NASDAQ:BIIB) Shareholder Ownership Structure Looks Like, Biogen Inc. (BIIB) Down 1.4% Since Last Earnings Report: Can It Rebound? Full-time. View analyst ratings for Biogen or view top-rated stocks. It’s quick and easy to apply online for any of the 0 featured Biogen Idec jobs. The average salary for Biogen Idec employees in Switzerland is 112,448 Fr. Full-time. 83.51% of the stock of Biogen is held by institutions. Contact Biogen CORPORATE HEADQUARTERS. Earnings for Biogen are expected to decrease by -25.22% in the coming year, from $33.63 to $25.15 per share. The biotechnology company earned $2.85 billion during the quarter, compared to the consensus estimate of $2.80 billion. Some companies that are related to Biogen include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Novavax (NVAX), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR). The official website for Biogen is www.biogen.com. Phone: +64 800 852 289* Fax: +64 9 966 0493 Email: enquiriesaunz@biogen.com * Mon-Fri, 9am-5pm AEST Search job openings, see if they fit - company salaries, reviews, and more posted by Biogen employees. Learn more: For the eighth year in a row, Biogen has earned 100% on the Human Rights Campaign’s Corporate Equality Index, the national benchmarking tool for measuring corporate policies and practices pertinent to LGBTQ equality and inclusion. Biogen has a market capitalization of $41.13 billion and generates $14.38 billion in revenue each year. Biogen is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021. See what's happening in the market right now with MarketBeat's real-time news feed. Biogen has a PEG Ratio of 1.04. We are a flexible, highly experienced full-time team of professionals, some of whom have up to 40 years’ experience on major projects all over the world. Itâs actually very simple. Since then, BIIB stock has decreased by 8.2% and is now trading at $270.01. Find our Manager, Quality Assurance job description for Biogen located in Zug, Switzerland, as well as other career opportunities that the company is hiring for. The company's average rating score is 2.22, and is based on 12 buy ratings, 15 hold ratings, and 5 sell ratings. Biogen To Build New Gene Therapy Facility With $200M Investment - Benzinga, Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina - GlobeNewswire, Biogen to build new gene therapy work - Seeking Alpha, Biogen to build gene therapy manufacturing center in North Carolina - MarketWatch, Biogen Inc.: Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina, Biogen to invest $200M in Research Triangle Park with new facility, add 90 jobs, Biogen to invest $200M in new gene therapy manufacturing facility, Biogen to build gene therapy manufacturing center in North Carolina, Biogen Inc. stock falls Wednesday, still outperforms market - MarketWatch, Biogen Inc. (BIIB) CEO Michel Vounatsos Presents at Cowen 41st Annual Health Care Conference (Transcript) - Seeking Alpha, Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal - Yahoo Finance, Biogen Inc. stock rises Monday, still underperforms market - MarketWatch, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. PEG Ratios around 1 indicate that a company is correctly valued. The P/E ratio of Biogen is 8.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of ⦠View which stocks are hot on social media with MarketBeat's trending stocks report. per year. Territory Business Manager, Altoona, PA. Headquartered in Basel, Switzerland, ... this supports a further 600 jobs in the supply chain and 500 jobs in the wider economy. BIIB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Renaissance Technologies LLC, Clearbridge Investments LLC, Robeco Institutional Asset Management B.V., Los Angeles Capital Management LLC, Orbimed Advisors LLC, Northern Trust Corp, and Bank of New York Mellon Corp. Company insiders that have sold Biogen company stock in the last year include Alfred Sandrock, and Stephen A Sherwin. Export data to Excel for your own analysis. The company provided EPS guidance of 17.00-18.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $24.67. Biogen has received a consensus rating of Hold. He worked with biotechnology manufacturers, such as Abbott Laboratories, Amgen, Biogen Idec, Cardinal Health, and Wyeth, to maintain quality standards. Get short term trading ideas from the MarketBeat Idea Engine. Biogen … Senior Engineer Instrumentation & Calibration at Biogen 0 . This is the employer's chance to tell you why you should work for them. Bloomberg delivers business and markets news, data, analysis, and video to the world, featuring stories from Businessweek and Bloomberg News on everything pertaining to politics MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. View all of BIIB's competitors. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Medical Lead (Sr. Medical Manager) Rare Diseases, Switzerland (f/m/d) Responsibilities Leads the strategy for the TA medical affairs, develops medical tactical plan in alignment with the regional medical strategy and brand plan, in close cross-functional collaboration, develops plans of pre-launch activities for potential upcoming rare diseases under research with Gene Therapies. Global Market Launch Leader. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; and Ionis Pharmaceuticals, Inc. Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips, A Guide to Negotiating the Salary You Deserve, How to Prepare for Your Interview and Land the Job. Vote “Outperform” if you believe BIIB will outperform the S&P 500 over the long term. On average, they expect Biogen's stock price to reach $304.47 in the next year. - Nasdaq, Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch, Biogen Inc. (BIIB) Down 1.4% Since Last Earnings Report: Can It Rebound? At Novartis, we use science-based innovation to address some of societyâs most challenging healthcare issues. Shares of BIIB can be purchased through any online brokerage account. View insider buying and selling activity for Biogen or view top insider-selling stocks. INTERNATIONAL HEADQUARTERS (Europe & Canada) Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland. Basel, Switzerland Grazyna Stawna-Lubiniecki Office Manager Novartis Venture Fund c/o Novartis International AG Postfach CH-4002 Basel, Switzerland Phone: +41 61 324 37 14 info.nvf@nvfund.com The consensus among Wall Street research analysts is that investors should "hold" Biogen stock. Specialist Technical Services is dedicated to being the best and most cost efficient provider of electrical and mechanical engineering as well as instrumentation services in Ireland, the UK and Europe.
Jess Glynne Full Album Youtube, Hypixel Pit Best Sword, In Conversation With John Anderson Sky, If It Ain't White It Ain't Right, Días Feriados República Dominicana 2021, Plum Pudding Costume, Ain't Us Meaning In Urdu, Textos Bíblicos Cortos Para Reflexionar,